Prospective, Multicentre, Open-Label Study Evaluating 1,5 mg/Day of Fondaparinux. - No Study Results Posted

Prospective, Multicentre, Open-Label Study Evaluating 1,5 mg/Day of Fondaparinux. (PROPICE)

This study has been completed.

Study NCT00555438 Information provided by Centre Hospitalier Universitaire de Saint Etienne

First Received: November 7, 2007 Last Updated: October 13, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2008
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)